JAK3/BTK-IN-4 is a potent inhibitor of JAK3/BTK, targeting critical pathways in autoimmune diseases. The simultaneous inhibition of the BTK/JAK3 signaling pathway exerts a synergistic effect, making JAK3/BTK-IN-4 a promising therapeutic candidate for JAK3 kinase and/or BTK-related diseases.
Molecular Weight:
440.93
CAS Number:
[2673196-38-6]
Formula:
C21H25ClN8O
Target:
Others|||BTK|||JAK
T62553
* VAT and and shipping costs not included. Errors and price changes excepted